The Addition of Dexamethasone to Bortezomib for Patients with Relapsed Multiple Myeloma Improves Outcome but Ongoing Maintenance Therapy Has Minimal Benefit.
American journal of hematology/oncology（2015）
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要